Literature DB >> 16049294

A rare presentation of zygomycosis (mucormycosis) and review of the literature.

M Karanth1, P Taniere, J Barraclough, J A Murray.   

Abstract

Zygomycosis (mucormycosis) is a rare fungal infection seen most often in association with prolonged neutropenia. Intestinal zygomycosis is extremely rare and difficult to diagnose, but it is important not to miss, because early medical and surgical treatment can improve survival. This report describes a 56 year old woman who developed this infection while receiving chemotherapy for acute lymphoblastic leukaemia. Medical and surgical measures proved unsuccessful because there was a delay in diagnosis and institution of appropriate treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16049294      PMCID: PMC1770885          DOI: 10.1136/jcp.2004.021816

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  CT and sonographically guided biopsy in a patient with intestinal mucormycosis.

Authors:  J H Lee; H K Ha; E Yoo; S K Yang; Y I Min; Y H Auh
Journal:  AJR Am J Roentgenol       Date:  2000-07       Impact factor: 3.959

Review 2.  Mucormycoses.

Authors:  J Eucker; O Sezer; B Graf; K Possinger
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

3.  Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto).

Authors:  L Pagano; P Ricci; A Tonso; A Nosari; L Cudillo; M Montillo; A Cenacchi; L Pacilli; F Fabbiano; A Del Favero
Journal:  Br J Haematol       Date:  1997-11       Impact factor: 6.998

4.  In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.

Authors:  A Gómez-López; M Cuenca-Estrella; A Monzón; J L Rodriguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2001-12       Impact factor: 5.790

5.  In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

Authors:  Qiu N Sun; Annette W Fothergill; Dora I McCarthy; Michael G Rinaldi; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 6.  Voriconazole: a new triazole antifungal agent.

Authors:  Leonard B Johnson; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2003-02-10       Impact factor: 9.079

Review 7.  The first echinocandin: caspofungin.

Authors:  O A Cornely; Karina Schmitz; Sabine Aisenbrey
Journal:  Mycoses       Date:  2002       Impact factor: 4.377

8.  Mucormycosis: ten-year experience at a tertiary-care center in Greece.

Authors:  G Petrikkos; A Skiada; H Sambatakou; A Toskas; G Vaiopoulos; M Giannopoulou; N Katsilambros
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

Review 9.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

10.  In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model.

Authors:  Qiu N Sun; Laura K Najvar; Rosie Bocanegra; David Loebenberg; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more
  11 in total

1.  Mucormycosis in Mato Grosso, Brazil: a case reports, caused by Rhizopus microsporus var. oligosporus and Rhizopus microsporus var. rhizopodiformis.

Authors:  Luciano Corrêa Ribeiro; Bodo Wanke; Manuela da Silva; Luciana Basili Dias; Renato Mello; Fernando Artur Pena Borges Canavarros; Diniz Pereira Leite; Rosane Christine Hahn
Journal:  Mycopathologia       Date:  2011-09-28       Impact factor: 2.574

2.  First case of gastrointestinal mucormycosis in an immunocompromised patient with gallbladder and duodenum involvement.

Authors:  E Lacarrière; L Lacaze; L Schwarz; E Huet; F Lemoine; M Scotté
Journal:  Infection       Date:  2011-07-23       Impact factor: 3.553

Review 3.  Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon's perspective.

Authors:  Oswens Siu-Hung Lo; Wai-Lun Law
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

4.  Successful treatment of disseminated mucormycosis in a neutropenic patient with T-cell acute lymphoblastic leukaemia.

Authors:  Chelsea Guymer; Sanjeev Khurana; Ram Suppiah; Iain Hennessey; Celia Cooper
Journal:  BMJ Case Rep       Date:  2013-07-31

5.  Histomorphological features of mucormycosis with rise and fall of COVID-19 pandemic.

Authors:  Nidhya Ganesan; Shanthakumari Sivanandam
Journal:  Pathol Res Pract       Date:  2022-06-17       Impact factor: 3.309

6.  Rhino-orbital mucourmycosis in a non-immunocompromised patient.

Authors:  Asifur Rahman; Khaleda Akter; Shakhawat Hossain; Harun Ur Rashid
Journal:  BMJ Case Rep       Date:  2013-02-06

7.  [Mucormycosis in paranasal sinuses].

Authors:  S Volkenstein; C Unkel; A Neumann; H Sudhoff; H Dermoumi; K Jahnke; S Dazert
Journal:  HNO       Date:  2009-08       Impact factor: 1.284

8.  Diagnostic Dilemma in Appendiceal Mucormycosis: A Rare Case Report.

Authors:  Sali Priyanka Akhilesh; Yadav Kamal Sunder; Pande Prasad; George Mary Asha; Agarwal Mohan; Mehta Hitesh
Journal:  Case Rep Surg       Date:  2016-08-18

9.  Nosocomial Jejunal Mucormycosis - an Unusual Cause of Perforation Peritonitis.

Authors:  Chandan Kumar; Pragya Jain; Neelam Wadhwa; Preeti Diwaker; Khan Nirupma Panikar
Journal:  Iran J Pathol       Date:  2017-07-01

10.  Difficult diagnosis of invasive fungal infection predominantly involving the lower gastrointestinal tract in acute lymphoblastic leukaemia.

Authors:  Gulhadiye Avcu; Deniz Yilmaz Karapinar; Pinar Yazici; Muhterem Duyu; Suleyha Hilmioglu Polat; Berna Atabay; Basak Doganavsargil; Bulent Karapinar
Journal:  Med Mycol Case Rep       Date:  2016-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.